Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial

Related documents

• Plasma proteomics link menopause timing to brain aging and dementia risk#169091
• Congestion-aware pick-up and drop-off network design problem#171128
• Development and utilization of irrigation simulation with CERES-Maize in a central Iowa cornfield#171129
• An investigation into the effect of clinical states of infection on pharmacokinetics and pharmacodynamics in ruminant food animal species#171130
• One dimensional model and pulse generation of a supercharger#171131